Steven Stein
Chief Tech/Sci/R&D Officer at INCYTE CORPORATION
Net worth: 6 M $ as of 2024-03-30
Profile
Steven H. Stein holds the position of Chief Medical Officer & Executive Vice President at Incyte Corp. Dr. Stein is also on the board of Kura Oncology, Inc. In his past career Dr. Stein was Vice President-Global Oncology at GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs at Novartis Oncology, Inc. and Senior VP-US Clinical Development & Medical Affair at Novartis Pharmaceuticals Corp. Dr. Stein received a doctorate from the University of the Witwatersrand.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INCYTE CORPORATION
0.04% | 2024-02-13 | 97,595 ( 0.04% ) | 6 M $ | 2024-03-30 |
KURA ONCOLOGY, INC.
-.--% | 2023-03-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Steven Stein active positions
| Companies | Position | Start |
|---|---|---|
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 2015-03-01 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
Former positions of Steven Stein
| Companies | Position | End |
|---|---|---|
| THESEUS PHARMACEUTICALS, INC. | Director/Board Member | 2024-02-13 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2015-01-31 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2015-01-31 |
| GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | 2011-03-31 |
| KURA ONCOLOGY, INC. | Director/Board Member | - |
Training of Steven Stein
| University of the Witwatersrand | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Steven Stein
